A Case Series of Refractory Cutaneous Sarcoidosis Successfully Treated with Infliximab

INTRODUCTION: Sarcoidosis is a systemic granulomatous disease of unknown cause. The management of sarcoidosis remains problematic. Systemic and topical corticosteroids are the mainstay of therapy but may cause unacceptable side effects. Biologic therapies, such as infliximab, have recently been prop...

Descripción completa

Detalles Bibliográficos
Autores principales: Tuchinda, Papapit, Bremmer, Matthew, Gaspari, Anthony A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare Communications 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510393/
https://www.ncbi.nlm.nih.gov/pubmed/23205333
http://dx.doi.org/10.1007/s13555-012-0011-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510393/
https://www.ncbi.nlm.nih.gov/pubmed/23205333
http://dx.doi.org/10.1007/s13555-012-0011-9

Ejemplares similares